Proactive Investors - Run By Investors For Investors

Ebiquity slides as it warns on flat profits for continuing business in 2019

The marketing and media consultancy said contractual obligations relating to the sale of its Advertising Intelligence business meant profitability would be "at a similar level to the year just ended”
Adverts
The firm sold its Advertising Intelligence arm to Nielsen Media Research in early January

Ebiquity plc (LON:EBQ) shares dropped in early trading Tuesday after the firm forecast flat profits from its continuing business in the new financial year.

In an update for the fiscal year ended 31 December 2018, the marketing and media consultancy said trading had been in line with expectations, adding that its year-end net debt of £28mln had been reduced by around £20mln post-period end after the sale of its advertising intelligence business to Nielsen Media Research Limited on 2 January 2019.

READ: Marketing group Ebiquity plummets as it warns on profits

Following the disposal, Ebiquity said it was targeting an 8% growth rate for its continuing consultancy business in 2019, similar to that of the prior year, however its cost base would continue to reflect the need to fulfil contractual obligations of providing support services to Nielsen in relation to the disposed business, and as such it expected profitability for the consultancy business to “remain at a similar level to the year just ended”.

Michael Karg, chief executive of Ebiquity, said the management team at the firm was now focused on “seizing the significant market opportunities as well as on aligning our business following the divestiture”.

Shares were down 8.2% at 56p.

View full EBQ profile View Profile

Ebiquity PLC Timeline

Newswire
October 01 2015
Newswire
February 13 2015

Related Articles

Apollo 11
February 22 2018
Immersive VR, a technology company focused on the education space, was the first company Sure backed
Students in a class
August 27 2018
The company is gaining traction in Asia where people are looking to take language courses to work or study internationally
ipad
September 19 2018
“Cello Health is successfully building its early stage asset development advisory platform for biotech clients, as well as growing its core later stage and post-launch franchise with pharmaceutical clients”
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use